Sort   by:  
 Page size 
UnknownFrom the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
Not available
S-EPMC7663810 | biostudies-literature
UnknownCannabis and Tobacco Co-Use Predicts Psychosis in Clinical High Risk Cohorts.
Not available
S-EPMC12458528 | biostudies-literature
UnknownEmergence and Dynamics of Delusions and Hallucinations Across Stages in Early Psychosis.
Not available
S-EPMC12353309 | biostudies-literature
UnknownSample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.
Not available
S-EPMC11968923 | biostudies-literature
UnknownCollecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative.
Not available
S-EPMC12528486 | biostudies-literature
UnknownThe MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.
Not available
S-EPMC11965426 | biostudies-literature
UnknownCognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample.
Not available
S-EPMC11933323 | biostudies-literature
UnknownThe electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures.
Not available
S-EPMC12144291 | biostudies-literature
Sort   by:  
 Page size